Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
This study was approved by the local university's ethics committee and conducted by the Declaration of Helsinki
GLP-1 alone, 6.3%
Always consult with a healthcare professional to determine the most appropriate dosage for your specific health goals and needs, ensuring that you balance efficacy with safety
Thangavelu T, Lyden E, Shivaswamy V
It is involved in the control of blood sugar level by enhancing insulin secretion.
Contraindications and precautions are not formally established due to the lack of regulatory approval, but clinical prudence suggests caution in: Pregnancy and breastfeeding (insufficient safety data) Individuals with active malignancy (theoretical concerns about enhanced cellular metabolism) Severe cardiovascular disease (due to reported chest symptoms) Known hypersensitivity to NAD or formulation components Patient safety advice : Individuals considering NAD injections should discuss this with their GP, particularly if they have underlying health conditions or take regular medications
